Related Experiment Video
Updated: Sep 6, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Insights
Digitalis improves cardiac performance in heart failure patients, even when clinical signs are absent. This cardiac drug offers hemodynamic benefits beyond basic rest and diuretic therapy.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Cardiac failure treatment involves rest, diuretics, and digitalis.
- The efficacy of digitalis in conjunction with other therapies is under investigation.
Purpose of the Study:
- To compare the effects of rest and diuretics versus rest, diuretics, and digitalis in treating cardiac failure.
- To evaluate the clinical and hemodynamic impact of digitalis in cardiac failure management.
Main Methods:
- A series of cardiac failure patients were treated with different therapeutic combinations.
- Clinical assessment and hemodynamic monitoring were employed to evaluate treatment outcomes.
Main Results:
- Most patients achieved compensation using rest and diuretics alone.
- Digitalis demonstrated favorable hemodynamic effects, improving cardiac performance.
- A discrepancy exists between clinical improvement and hemodynamic status in some patients.
Conclusions:
- Digitalis offers significant hemodynamic benefits in cardiac failure, even in the absence of clear clinical signs.
- Hemodynamic assessment is crucial for fully evaluating digitalis efficacy in cardiac failure.
Abstract:
TREATMENT OF CARDIAC FAILURE CONSISTS OF THREE PRINCIPAL METHODS OR A COMBINATION OF THEM: (a) rest, or reduction of overload; (b) diuretic therapy and sodium restriction, and (c) administration of digitalis. In a series of patients treatment with the aid of the first two methods was compared with the effect of adding digitalis to this regimen.Clinically, most patients can be brought back to a state of compensation without the use of digitalis. Hemodynamically, digitalis exerts a further favorable action by improving cardiac performance. The discrepancy between clinical and hemodynamic cardiac state is emphasized, for patients may have no clinical evidence of cardiac failure and yet show hemodynamic abnormalities characteristic of serious impairment of cardiac performance. Thus digitalis has been shown to exert a favorable effect in cardiac failure even if such an effect cannot be clinically assessed.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure V: Medical Management
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy V: Interprofessional Care